Skip to main content
. 2023 Sep 21;79(3):674–689. doi: 10.1097/HEP.0000000000000607

FIGURE 2.

FIGURE 2

Primary end point. (A) Change from baseline in ELF score at week 48. (B–D) Change from baseline to week 48 in the individual components of ELF: HA (B), PIIINP (C), and TIMP-1 (D). Shown are LS mean differences between the aldafermin group (1 or 3 mg) and the placebo group. Enrollment in the aldafermin 0.3 mg group was discontinued during the trial. Abbreviations: ELF, Enhanced Liver Fibrosis; HA, hyaluronic acid; LS, least-squares; PIIINP, N-terminal pro-peptide of type III collagen.